Sequence variation at two eosinophil-associated ribonuclease loci in humans

被引:0
|
作者
Zhang, J [1 ]
Rosenberg, HF [1 ]
机构
[1] NIAID, Host Def Lab, NIH, Bethesda, MD 20892 USA
关键词
D O I
暂无
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Host defense against invading pathogens is of great importance to the survival of higher organisms. We hale been studying the evolution of mammalian eosinophil-associated ribonucleases (EARs), which ar-e members of the ribonuclease A super-family with known antipathogen activities. Earlier studies showed that positive: selection promoted rapid diversification of paralogous EAR. genes in both primates and rodents. Intraspecifically, however, it is unknown whether these genes also have divergent alleles. The recent discovery that the gene repertoire of the EAR family is much larger in rodents than in primates has led us to consider the possibility that primates maintain a large number of polymorphic alleles to compensate for a smaller gene repertoire. Here we present sequences of 2417 nucleotides at the two EAR loci, the eosinophil-derived neurotoxin (EDN, RNase 2) and eosinophil cationic protein (ECP, RNase 3), from >50 human individuals. Our data demonstrate dial the nucleotide diversities (0.06-0.11%) at these loci are typical for human nuclear genes, thus permitting us to reject this polymorphism hypothesis. No significant departure from neutrality is noted and no signs of overdominant selection are observed. Similar patterns were observed in a preliminary study of chimpanzees. In summary, our results suggest that the antipathogen functions of the primate EARs are conserved after they are established and that these proteins are not currently undergoing rapid diversification in response to challenge from invading microorganisms.
引用
收藏
页码:1949 / 1958
页数:10
相关论文
共 50 条
  • [21] Eosinophil-Associated Gastrointestinal Manifestations During OIT
    Goldberg, Michael R.
    Epstein-Rigbi, Naama
    Elizur, Arnon
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2023, 65 (03) : 365 - 376
  • [22] Immunomodulatory therapy of eosinophil-associated gastrointestinal diseases
    Stone, K. D.
    Prussin, C.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2008, 38 (12): : 1858 - 1865
  • [23] Eosinophil-Associated Gastrointestinal Disorders with Asthma: Immunohistochemical Analyses
    Shirai, Toshihiro
    Komiyama, Akira
    Hayakawa, Hiroshi
    Hashimoto, Dai
    Suda, Takafumi
    Chida, Kingo
    INTERNAL MEDICINE, 2009, 48 (15) : 1315 - 1321
  • [24] Novel Targeted Therapies for Eosinophil-Associated Diseases and Allergy
    Radonjic-Hoesli, Susanne
    Valent, Peter
    Klion, Amy D.
    Wechsler, Michael E.
    Simon, Hans-Uwe
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 55, 2015, 55 : 633 - 656
  • [25] Mepolizumab for Eosinophil-Associated COPD: Analysis of METREX and METREO
    Pavord, Ian D.
    Chapman, Kenneth R.
    Bafadhel, Mona
    Sciurba, Frank C.
    Bradford, Eric S.
    Harris, Stephanie Schweiker
    Mayer, Bhabita
    Rubin, David B.
    Yancey, Steven W.
    Paggiaro, Pierluigi
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2021, 16 : 1755 - 1770
  • [26] Identification of a purine-rich intronic enhancer element in the mouse eosinophil-associated ribonuclease 2 (mEar 2) gene
    Dyer, KD
    Nitto, T
    Moreau, JM
    McDevitt, AL
    Rosenberg, HF
    MAMMALIAN GENOME, 2004, 15 (02) : 126 - 134
  • [27] Identification of a purine-rich intronic enhancer element in the mouse eosinophil-associated ribonuclease 2 (mEar 2) gene
    Kimberly D. Dyer
    Takeaki Nitto
    Joanne M. Moreau
    Amanda L. McDevitt
    Helene F. Rosenberg
    Mammalian Genome, 2004, 15 : 126 - 134
  • [28] Improving Care in Eosinophil-Associated Diseases: A Charter COMMENT
    Jackson, David J.
    Akuthota, Praveen
    Andradas, Rebeca
    Bredenoord, Albert J.
    Cordell, Amanda
    Gray, Sarah
    Kullman, Joyce
    Mathur, Sameer K.
    Pavord, Ian
    Roufosse, Florence
    Rubio, Christian
    Rusek, Irena Clisson
    Simon, Dagmar
    Strobel, Mary Jo
    Winders, Tonya
    ADVANCES IN THERAPY, 2022, 39 (06) : 2323 - 2341
  • [29] Management of eosinophil-associated inflammatory diseases: the importance of a multidisciplinary approach
    Quirce, Santiago
    Cosio, Borja G.
    Espana, Agustin
    Blanco, Ricardo
    Mullol, Joaquim
    Santander, Cecilio
    del Pozo, Victoria
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [30] Eosinophil-Associated Genes are Potential Biomarkers for Hepatocellular Carcinoma Prognosis
    Wang, Qinghao
    Zhang, Zixin
    Zhou, Hao
    Qin, Yanling
    He, Jun
    Li, Limin
    Ding, Xiaofeng
    JOURNAL OF CANCER, 2024, 15 (17): : 5605 - 5621